ACB - Aurora Cannabis reports Q4 results; initiates Q1 outlook
2024-06-20 07:05:03 ET
- Aurora Cannabis press release ( NASDAQ: ACB ): Q4 net loss from continuing operations for the three months ended March 31, 2024, was C$20.8 million, compared to net loss of C$76.2 million for the prior year period.
- Revenue of C$67.41M (+5.4% Y/Y).
- Medical cannabis net revenue was C$45.6 million, a 20% increase from the prior year quarter.
- Adjusted EBITDA was C$1.9 million for the three months ended March 31, 2024, compared to C$2.0 million for the prior year quarter.
- Outlook: Fiscal Q1 2025 Expectations:
- In Q1 2025, the period ending June 30, 2024, the company expects to achieve consolidated net revenue percentage growth in the mid to high teens from Q4 2024.
More on Aurora Cannabis:
- Aurora Cannabis: Improved Financials, Limited Opportunity
- Aurora Cannabis: Recent Performance Improvements Are Undeniable
- Aurora Cannabis Q4 earnings expectations and market predictions
- Pot stocks rally snuffed day after DEA marijuana rescheduling development
- Seeking Alpha’s Quant Rating on Aurora Cannabis